bionlp-st-ge-2016-spacy-parsed Home  

PMC:3312845 / 6715-8147 JSONTXT 23 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T3583 0-23 JJ denotes Intracerebroventricular
T3584 24-28 NN denotes drug
T3585 29-37 NN denotes infusion
T3586 38-42 NNS denotes Rats
T3587 43-47 VBD denotes were
T3588 48-55 VBN denotes divided
T3589 56-60 IN denotes into
T3590 61-64 CD denotes two
T3591 65-71 NNS denotes groups
T3592 71-72 : denotes :
T3593 73-80 NN denotes vehicle
T3594 81-82 -LRB- denotes (
T3595 82-88 NN denotes saline
T3596 88-89 -RRB- denotes )
T3597 89-90 : denotes -
T3598 90-97 VBN denotes treated
T3599 98-101 CC denotes and
T3600 102-109 JJ denotes soluble
T3601 110-116 NN denotes TNFp55
T3602 117-125 NN denotes receptor
T3603 126-127 -LRB- denotes (
T3604 127-135 JJ denotes sTNFp55R
T3605 135-136 , denotes ,
T3606 137-139 CD denotes 50
T3607 140-142 NN denotes μg
T3608 142-143 NN denotes /
T3609 143-145 NN denotes ml
T3610 145-146 : denotes ;
T3611 147-160 NNP denotes Sigma-Aldrich
T3612 161-164 NNP denotes Co.
T3613 164-165 , denotes ,
T3614 166-169 NNP denotes St.
T3615 170-175 NNP denotes Louis
T3616 175-176 , denotes ,
T3617 177-179 NNP denotes MO
T3618 179-180 -RRB- denotes )
T3619 180-181 : denotes -
T3620 181-188 VBN denotes treated
T3621 189-195 NNS denotes groups
T3622 195-196 . denotes .
T3623 197-200 DT denotes The
T3624 201-207 NN denotes dosage
T3625 208-210 IN denotes of
T3626 211-219 NN denotes sTNFp55R
T3627 220-223 VBD denotes was
T3628 224-234 VBN denotes determined
T3629 235-237 IN denotes as
T3630 238-241 DT denotes the
T3631 242-249 JJS denotes highest
T3632 250-254 NN denotes dose
T3633 255-259 WDT denotes that
T3634 260-267 VBD denotes induced
T3635 268-270 NNP denotes SE
T3636 271-273 IN denotes of
T3637 274-284 JJ denotes comparable
T3638 285-293 NN denotes severity
T3639 294-296 IN denotes in
T3640 297-300 CD denotes 100
T3641 300-301 NN denotes %
T3642 302-304 IN denotes of
T3643 305-312 NNS denotes animals
T3644 313-317 IN denotes with
T3645 318-319 CD denotes 5
T3646 319-320 NN denotes %
T3647 321-330 NN denotes mortality
T3648 331-333 IN denotes in
T3649 334-337 DT denotes the
T3650 338-349 JJ denotes preliminary
T3651 350-355 NN denotes study
T3652 355-356 . denotes .
T3653 357-364 NNS denotes Animals
T3654 365-369 VBD denotes were
T3655 370-382 JJ denotes anesthetized
T3656 383-384 -LRB- denotes (
T3657 384-392 NNP denotes Zolretil
T3658 392-393 , denotes ,
T3659 394-396 CD denotes 50
T3660 397-402 NN denotes mg/kg
T3661 402-403 , denotes ,
T3662 404-408 NN denotes i.m.
T3663 408-409 : denotes ;
T3664 410-416 NNP denotes Virbac
T3665 417-429 NNPS denotes Laboratories
T3666 429-430 , denotes ,
T3667 431-437 NNP denotes France
T3668 437-438 -RRB- denotes )
T3669 439-442 CC denotes and
T3670 443-449 VBN denotes placed
T3671 450-452 IN denotes in
T3672 453-454 DT denotes a
T3673 455-466 JJ denotes stereotaxic
T3674 467-473 NNS denotes frames
T3675 473-474 . denotes .
T3676 475-478 IN denotes For
T3677 479-482 DT denotes the
T3678 483-490 JJ denotes osmotic
T3679 491-495 NN denotes pump
T3680 496-508 NN denotes implantation
T3681 508-509 , denotes ,
T3682 510-515 NNS denotes holes
T3683 516-520 VBD denotes were
T3684 521-528 VBN denotes drilled
T3685 529-536 IN denotes through
T3686 537-540 DT denotes the
T3687 541-546 NN denotes skull
T3688 547-549 TO denotes to
T3689 550-559 VB denotes introduce
T3690 560-561 DT denotes a
T3691 562-567 NN denotes brain
T3692 568-576 NN denotes infusion
T3693 577-580 NN denotes kit
T3694 581-582 CD denotes 1
T3695 583-584 -LRB- denotes (
T3696 584-589 NNP denotes Alzet
T3697 589-590 , denotes ,
T3698 591-600 NNP denotes Cupertino
T3699 600-601 , denotes ,
T3700 602-604 NNP denotes CA
T3701 604-605 -RRB- denotes )
T3702 606-610 IN denotes into
T3703 611-614 DT denotes the
T3704 615-620 JJ denotes right
T3705 621-628 JJ denotes lateral
T3706 629-638 NN denotes ventricle
T3707 639-640 -LRB- denotes (
T3708 640-641 CD denotes 1
T3709 642-644 NN denotes mm
T3710 645-654 NN denotes posterior
T3711 654-655 : denotes ;
T3712 656-659 CD denotes 1.5
T3713 660-662 NN denotes mm
T3714 663-670 NN denotes lateral
T3715 670-671 : denotes ;
T3716 672-673 : denotes -
T3717 674-677 CD denotes 3.5
T3718 678-680 NN denotes mm
T3719 681-686 NN denotes depth
T3720 686-687 : denotes ;
T3721 688-692 JJ denotes flat
T3722 693-698 NN denotes skull
T3723 699-707 NN denotes position
T3724 708-712 IN denotes with
T3725 713-719 NN denotes bregma
T3726 720-722 IN denotes as
T3727 723-732 NN denotes reference
T3728 732-733 -RRB- denotes )
T3729 733-734 , denotes ,
T3730 735-744 VBG denotes according
T3731 745-747 TO denotes to
T3732 748-751 DT denotes the
T3733 752-757 NNS denotes atlas
T3734 758-760 IN denotes of
T3735 761-768 NNP denotes Paxinos
T3736 769-772 CC denotes and
T3737 773-779 NNP denotes Watson
T3738 780-781 NNP denotes [
T3739 781-783 CD denotes 24
T3740 783-784 NNP denotes ]
T3741 784-785 . denotes .
T3742 786-789 DT denotes The
T3743 790-798 NN denotes infusion
T3744 799-802 NN denotes kit
T3745 803-806 VBD denotes was
T3746 807-813 VBN denotes sealed
T3747 814-818 IN denotes with
T3748 819-825 JJ denotes dental
T3749 826-832 NN denotes cement
T3750 833-836 CC denotes and
T3751 837-846 VBN denotes connected
T3752 847-849 TO denotes to
T3753 850-852 DT denotes an
T3754 853-860 JJ denotes osmotic
T3755 861-865 NN denotes pump
T3756 866-867 -LRB- denotes (
T3757 867-872 NNP denotes 1007D
T3758 872-873 , denotes ,
T3759 874-879 NNP denotes Alzet
T3760 879-880 , denotes ,
T3761 881-890 NNP denotes Cupertino
T3762 890-891 , denotes ,
T3763 892-894 NNP denotes CA
T3764 894-895 -RRB- denotes )
T3765 895-896 . denotes .
T3766 897-900 DT denotes The
T3767 901-905 NN denotes pump
T3768 906-909 VBD denotes was
T3769 910-916 VBN denotes placed
T3770 917-919 IN denotes in
T3771 920-921 DT denotes a
T3772 922-934 JJ denotes subcutaneous
T3773 935-941 NN denotes pocket
T3774 942-944 IN denotes in
T3775 945-948 DT denotes the
T3776 949-955 JJ denotes dorsal
T3777 956-962 NN denotes region
T3778 962-963 . denotes .
T3779 964-971 NNS denotes Animals
T3780 972-980 VBD denotes received
T3781 981-984 CD denotes 0.5
T3782 985-987 NN denotes μl
T3783 987-988 NN denotes /
T3784 988-990 NN denotes hr
T3785 991-993 IN denotes of
T3786 994-1001 NN denotes vehicle
T3787 1002-1004 CC denotes or
T3788 1005-1013 NN denotes compound
T3789 1014-1017 IN denotes for
T3790 1018-1019 CD denotes 1
T3791 1020-1024 NN denotes week
T3792 1024-1025 . denotes .
T3793 1026-1035 RB denotes Therefore
T3794 1035-1036 , denotes ,
T3795 1037-1040 DT denotes the
T3796 1041-1045 NN denotes dose
T3797 1046-1048 IN denotes of
T3798 1049-1057 NN denotes sTNFp55R
T3799 1058-1061 VBD denotes was
T3800 1062-1065 CD denotes 0.6
T3801 1066-1068 NN denotes μg
T3802 1068-1069 NN denotes /
T3803 1069-1072 NN denotes day
T3804 1073-1076 IN denotes per
T3805 1077-1081 DT denotes each
T3806 1082-1088 NN denotes animal
T3807 1088-1089 . denotes .
T3808 1090-1093 DT denotes The
T3809 1094-1103 NNS denotes compounds
T3810 1104-1109 VBD denotes began
T3811 1110-1112 TO denotes to
T3812 1113-1115 VB denotes be
T3813 1116-1127 RB denotes immediately
T3814 1128-1135 VBN denotes infused
T3815 1136-1141 IN denotes after
T3816 1142-1149 NN denotes surgery
T3817 1149-1150 . denotes .
T3818 1151-1156 IN denotes Since
T3819 1157-1160 DT denotes the
T3820 1161-1167 NN denotes volume
T3821 1168-1170 IN denotes of
T3822 1171-1180 JJ denotes vasogenic
T3823 1181-1186 NN denotes edema
T3824 1187-1193 VBD denotes peaked
T3825 1194-1196 IN denotes at
T3826 1197-1200 CD denotes 2-3
T3827 1201-1205 NNS denotes days
T3828 1206-1211 IN denotes after
T3829 1212-1214 NNP denotes SE
T3830 1215-1217 IN denotes in
T3831 1218-1221 PRP$ denotes our
T3832 1222-1230 JJ denotes previous
T3833 1231-1238 NNS denotes studies
T3834 1239-1240 NNP denotes [
T3835 1240-1243 CD denotes 5-8
T3836 1243-1246 CD denotes ,20
T3837 1246-1247 NNP denotes ]
T3838 1247-1248 , denotes ,
T3839 1249-1251 PRP denotes we
T3840 1252-1257 VBD denotes chose
T3841 1258-1262 DT denotes this
T3842 1263-1267 NN denotes time
T3843 1268-1273 NN denotes point
T3844 1273-1274 . denotes .
T3845 1275-1279 RB denotes Thus
T3846 1279-1280 , denotes ,
T3847 1281-1284 PRP$ denotes our
T3848 1285-1297 JJ denotes experimental
T3849 1298-1307 NNS denotes schedules
T3850 1308-1310 IN denotes at
T3851 1311-1316 JJS denotes least
T3852 1317-1324 VB denotes inhibit
T3853 1325-1328 DT denotes the
T3854 1329-1337 NN denotes function
T3855 1338-1340 IN denotes of
T3856 1341-1346 NN denotes TNF-α
T3857 1347-1351 IN denotes from
T3858 1352-1353 CD denotes 3
T3859 1354-1358 NNS denotes days
T3860 1359-1364 RB denotes prior
T3861 1365-1367 TO denotes to
T3862 1368-1370 VB denotes SE
T3863 1371-1373 TO denotes to
T3864 1374-1375 CD denotes 4
T3865 1376-1380 NNS denotes days
T3866 1381-1386 IN denotes after
T3867 1387-1389 NNP denotes SE
T3868 1390-1394 WRB denotes when
T3869 1395-1398 DT denotes the
T3870 1399-1405 NN denotes volume
T3871 1406-1408 IN denotes of
T3872 1409-1418 JJ denotes vasogenic
T3873 1419-1424 NN denotes edema
T3874 1425-1431 VBD denotes peaked
T3875 1431-1432 . denotes .
R2728 T3583 T3585 amod Intracerebroventricular,infusion
R2729 T3584 T3585 compound drug,infusion
R2730 T3585 T3586 compound infusion,Rats
R2731 T3586 T3588 nsubjpass Rats,divided
R2732 T3587 T3588 auxpass were,divided
R2733 T3588 T3588 ROOT divided,divided
R2734 T3589 T3588 prep into,divided
R2735 T3590 T3591 nummod two,groups
R2736 T3591 T3589 pobj groups,into
R2737 T3592 T3591 punct :,groups
R2738 T3593 T3591 appos vehicle,groups
R2739 T3594 T3595 punct (,saline
R2740 T3595 T3593 appos saline,vehicle
R2741 T3596 T3593 punct ),vehicle
R2742 T3597 T3593 punct -,vehicle
R2743 T3598 T3593 acl treated,vehicle
R2744 T3599 T3598 cc and,treated
R2745 T3600 T3598 conj soluble,treated
R2746 T3601 T3602 compound TNFp55,receptor
R2747 T3602 T3620 ccomp receptor,treated
R2748 T3603 T3609 punct (,ml
R2749 T3604 T3609 amod sTNFp55R,ml
R2750 T3605 T3609 punct ",",ml
R2751 T3606 T3607 nummod 50,μg
R2752 T3607 T3609 nmod μg,ml
R2753 T3608 T3609 compound /,ml
R2754 T3609 T3602 appos ml,receptor
R2755 T3610 T3620 punct ;,treated
R2756 T3611 T3612 compound Sigma-Aldrich,Co.
R2757 T3612 T3620 nsubj Co.,treated
R2758 T3613 T3612 punct ",",Co.
R2759 T3614 T3615 compound St.,Louis
R2760 T3615 T3612 npadvmod Louis,Co.
R2761 T3616 T3612 punct ",",Co.
R2762 T3617 T3612 appos MO,Co.
R2763 T3618 T3617 punct ),MO
R2764 T3619 T3620 punct -,treated
R2765 T3620 T3621 amod treated,groups
R2766 T3621 T3591 appos groups,groups
R2767 T3622 T3588 punct .,divided
R2768 T3623 T3624 det The,dosage
R2769 T3624 T3628 nsubjpass dosage,determined
R2770 T3625 T3624 prep of,dosage
R2771 T3626 T3625 pobj sTNFp55R,of
R2772 T3627 T3628 auxpass was,determined
R2773 T3628 T3628 ROOT determined,determined
R2774 T3629 T3628 prep as,determined
R2775 T3630 T3632 det the,dose
R2776 T3631 T3632 amod highest,dose
R2777 T3632 T3629 pobj dose,as
R2778 T3633 T3634 nsubj that,induced
R2779 T3634 T3632 relcl induced,dose
R2780 T3635 T3634 dobj SE,induced
R2781 T3636 T3635 prep of,SE
R2782 T3637 T3638 amod comparable,severity
R2783 T3638 T3636 pobj severity,of
R2784 T3639 T3634 prep in,induced
R2785 T3640 T3641 nummod 100,%
R2786 T3641 T3639 pobj %,in
R2787 T3642 T3641 prep of,%
R2788 T3643 T3642 pobj animals,of
R2789 T3644 T3634 prep with,induced
R2790 T3645 T3646 nummod 5,%
R2791 T3646 T3647 compound %,mortality
R2792 T3647 T3644 pobj mortality,with
R2793 T3648 T3647 prep in,mortality
R2794 T3649 T3651 det the,study
R2795 T3650 T3651 amod preliminary,study
R2796 T3651 T3648 pobj study,in
R2797 T3652 T3628 punct .,determined
R2798 T3653 T3654 nsubj Animals,were
R2799 T3654 T3665 ccomp were,Laboratories
R2800 T3655 T3654 acomp anesthetized,were
R2801 T3656 T3657 punct (,Zolretil
R2802 T3657 T3665 ccomp Zolretil,Laboratories
R2803 T3658 T3657 punct ",",Zolretil
R2804 T3659 T3660 nummod 50,mg/kg
R2805 T3660 T3657 appos mg/kg,Zolretil
R2806 T3661 T3662 punct ",",i.m.
R2807 T3662 T3657 conj i.m.,Zolretil
R2808 T3663 T3665 punct ;,Laboratories
R2809 T3664 T3665 compound Virbac,Laboratories
R2810 T3665 T3665 ROOT Laboratories,Laboratories
R2811 T3666 T3665 punct ",",Laboratories
R2812 T3667 T3665 conj France,Laboratories
R2813 T3668 T3667 punct ),France
R2814 T3669 T3665 cc and,Laboratories
R2815 T3670 T3665 conj placed,Laboratories
R2816 T3671 T3670 prep in,placed
R2817 T3672 T3674 det a,frames
R2818 T3673 T3674 amod stereotaxic,frames
R2819 T3674 T3671 pobj frames,in
R2820 T3675 T3665 punct .,Laboratories
R2821 T3676 T3684 prep For,drilled
R2822 T3677 T3680 det the,implantation
R2823 T3678 T3680 amod osmotic,implantation
R2824 T3679 T3680 compound pump,implantation
R2825 T3680 T3676 pobj implantation,For
R2826 T3681 T3684 punct ",",drilled
R2827 T3682 T3684 nsubjpass holes,drilled
R2828 T3683 T3684 auxpass were,drilled
R2829 T3684 T3684 ROOT drilled,drilled
R2830 T3685 T3684 prep through,drilled
R2831 T3686 T3687 det the,skull
R2832 T3687 T3685 pobj skull,through
R2833 T3688 T3689 aux to,introduce
R2834 T3689 T3684 advcl introduce,drilled
R2835 T3690 T3693 det a,kit
R2836 T3691 T3692 compound brain,infusion
R2837 T3692 T3693 compound infusion,kit
R2838 T3693 T3689 dobj kit,introduce
R2839 T3694 T3693 nummod 1,kit
R2840 T3695 T3693 punct (,kit
R2841 T3696 T3693 appos Alzet,kit
R2842 T3697 T3696 punct ",",Alzet
R2843 T3698 T3696 conj Cupertino,Alzet
R2844 T3699 T3698 punct ",",Cupertino
R2845 T3700 T3698 conj CA,Cupertino
R2846 T3701 T3693 punct ),kit
R2847 T3702 T3689 prep into,introduce
R2848 T3703 T3706 det the,ventricle
R2849 T3704 T3706 amod right,ventricle
R2850 T3705 T3706 amod lateral,ventricle
R2851 T3706 T3702 pobj ventricle,into
R2852 T3707 T3710 punct (,posterior
R2853 T3708 T3709 nummod 1,mm
R2854 T3709 T3710 compound mm,posterior
R2855 T3710 T3723 compound posterior,position
R2856 T3711 T3710 punct ;,posterior
R2857 T3712 T3713 nummod 1.5,mm
R2858 T3713 T3714 compound mm,lateral
R2859 T3714 T3710 appos lateral,posterior
R2860 T3715 T3710 punct ;,posterior
R2861 T3716 T3710 punct -,posterior
R2862 T3717 T3718 nummod 3.5,mm
R2863 T3718 T3719 compound mm,depth
R2864 T3719 T3710 appos depth,posterior
R2865 T3720 T3710 punct ;,posterior
R2866 T3721 T3722 amod flat,skull
R2867 T3722 T3723 compound skull,position
R2868 T3723 T3689 dobj position,introduce
R2869 T3724 T3689 prep with,introduce
R2870 T3725 T3724 pobj bregma,with
R2871 T3726 T3689 prep as,introduce
R2872 T3727 T3726 pobj reference,as
R2873 T3728 T3689 punct ),introduce
R2874 T3729 T3684 punct ",",drilled
R2875 T3730 T3684 prep according,drilled
R2876 T3731 T3730 prep to,according
R2877 T3732 T3733 det the,atlas
R2878 T3733 T3731 pobj atlas,to
R2879 T3734 T3733 prep of,atlas
R2880 T3735 T3734 pobj Paxinos,of
R2881 T3736 T3735 cc and,Paxinos
R2882 T3737 T3738 compound Watson,[
R2883 T3738 T3735 conj [,Paxinos
R2884 T3739 T3740 nummod 24,]
R2885 T3740 T3735 conj ],Paxinos
R2886 T3741 T3684 punct .,drilled
R2887 T3742 T3744 det The,kit
R2888 T3743 T3744 compound infusion,kit
R2889 T3744 T3746 nsubjpass kit,sealed
R2890 T3745 T3746 auxpass was,sealed
R2891 T3746 T3746 ROOT sealed,sealed
R2892 T3747 T3746 prep with,sealed
R2893 T3748 T3749 amod dental,cement
R2894 T3749 T3747 pobj cement,with
R2895 T3750 T3749 cc and,cement
R2896 T3751 T3746 conj connected,sealed
R2897 T3752 T3751 prep to,connected
R2898 T3753 T3755 det an,pump
R2899 T3754 T3755 amod osmotic,pump
R2900 T3755 T3752 pobj pump,to
R2901 T3756 T3755 punct (,pump
R2902 T3757 T3757 ROOT 1007D,1007D
R2903 T3758 T3757 punct ",",1007D
R2904 T3759 T3757 conj Alzet,1007D
R2905 T3760 T3759 punct ",",Alzet
R2906 T3761 T3759 conj Cupertino,Alzet
R2907 T3762 T3761 punct ",",Cupertino
R2908 T3763 T3761 conj CA,Cupertino
R2909 T3764 T3757 punct ),1007D
R2910 T3765 T3746 punct .,sealed
R2911 T3766 T3767 det The,pump
R2912 T3767 T3769 nsubjpass pump,placed
R2913 T3768 T3769 auxpass was,placed
R2914 T3769 T3769 ROOT placed,placed
R2915 T3770 T3769 prep in,placed
R2916 T3771 T3773 det a,pocket
R2917 T3772 T3773 amod subcutaneous,pocket
R2918 T3773 T3770 pobj pocket,in
R2919 T3774 T3773 prep in,pocket
R2920 T3775 T3777 det the,region
R2921 T3776 T3777 amod dorsal,region
R2922 T3777 T3774 pobj region,in
R2923 T3778 T3769 punct .,placed
R2924 T3779 T3780 nsubj Animals,received
R2925 T3780 T3780 ROOT received,received
R2926 T3781 T3782 nummod 0.5,μl
R2927 T3782 T3784 compound μl,hr
R2928 T3783 T3784 compound /,hr
R2929 T3784 T3780 dobj hr,received
R2930 T3785 T3784 prep of,hr
R2931 T3786 T3785 pobj vehicle,of
R2932 T3787 T3786 cc or,vehicle
R2933 T3788 T3786 conj compound,vehicle
R2934 T3789 T3780 prep for,received
R2935 T3790 T3791 nummod 1,week
R2936 T3791 T3789 pobj week,for
R2937 T3792 T3780 punct .,received
R2938 T3793 T3799 advmod Therefore,was
R2939 T3794 T3799 punct ",",was
R2940 T3795 T3796 det the,dose
R2941 T3796 T3799 nsubj dose,was
R2942 T3797 T3796 prep of,dose
R2943 T3798 T3797 pobj sTNFp55R,of
R2944 T3799 T3799 ROOT was,was
R2945 T3800 T3801 nummod 0.6,μg
R2946 T3801 T3803 amod μg,day
R2947 T3802 T3803 compound /,day
R2948 T3803 T3799 attr day,was
R2949 T3804 T3803 prep per,day
R2950 T3805 T3806 det each,animal
R2951 T3806 T3804 pobj animal,per
R2952 T3807 T3799 punct .,was
R2953 T3808 T3809 det The,compounds
R2954 T3809 T3810 nsubj compounds,began
R2955 T3810 T3810 ROOT began,began
R2956 T3811 T3814 aux to,infused
R2957 T3812 T3814 auxpass be,infused
R2958 T3813 T3814 advmod immediately,infused
R2959 T3814 T3810 xcomp infused,began
R2960 T3815 T3814 prep after,infused
R2961 T3816 T3815 pobj surgery,after
R2962 T3817 T3810 punct .,began
R2963 T3818 T3824 mark Since,peaked
R2964 T3819 T3820 det the,volume
R2965 T3820 T3824 nsubj volume,peaked
R2966 T3821 T3820 prep of,volume
R2967 T3822 T3823 amod vasogenic,edema
R2968 T3823 T3821 pobj edema,of
R2969 T3824 T3840 advcl peaked,chose
R2970 T3825 T3824 prep at,peaked
R2971 T3826 T3827 nummod 2-3,days
R2972 T3827 T3825 pobj days,at
R2973 T3828 T3840 prep after,chose
R2974 T3829 T3837 nmod SE,]
R2975 T3830 T3829 prep in,SE
R2976 T3831 T3833 poss our,studies
R2977 T3832 T3833 amod previous,studies
R2978 T3833 T3830 pobj studies,in
R2979 T3834 T3837 nmod [,]
R2980 T3835 T3834 nummod 5-8,[
R2981 T3836 T3837 compound ",20",]
R2982 T3837 T3828 pobj ],after
R2983 T3838 T3840 punct ",",chose
R2984 T3839 T3840 nsubj we,chose
R2985 T3840 T3840 ROOT chose,chose
R2986 T3841 T3843 det this,point
R2987 T3842 T3843 compound time,point
R2988 T3843 T3840 dobj point,chose
R2989 T3844 T3840 punct .,chose
R2990 T3845 T3852 advmod Thus,inhibit
R2991 T3846 T3852 punct ",",inhibit
R2992 T3847 T3849 poss our,schedules
R2993 T3848 T3849 amod experimental,schedules
R2994 T3849 T3852 nsubj schedules,inhibit
R2995 T3850 T3851 advmod at,least
R2996 T3851 T3852 advmod least,inhibit
R2997 T3852 T3852 ROOT inhibit,inhibit
R2998 T3853 T3854 det the,function
R2999 T3854 T3852 dobj function,inhibit
R3000 T3855 T3854 prep of,function
R3001 T3856 T3855 pobj TNF-α,of
R3002 T3857 T3852 prep from,inhibit
R3003 T3858 T3859 nummod 3,days
R3004 T3859 T3857 pobj days,from
R3005 T3860 T3852 advmod prior,inhibit
R3006 T3861 T3860 prep to,prior
R3007 T3862 T3861 pobj SE,to
R3008 T3863 T3862 prep to,SE
R3009 T3864 T3865 nummod 4,days
R3010 T3865 T3863 pobj days,to
R3011 T3866 T3852 prep after,inhibit
R3012 T3867 T3866 pobj SE,after
R3013 T3868 T3874 advmod when,peaked
R3014 T3869 T3870 det the,volume
R3015 T3870 T3874 nsubj volume,peaked
R3016 T3871 T3870 prep of,volume
R3017 T3872 T3873 amod vasogenic,edema
R3018 T3873 T3871 pobj edema,of
R3019 T3874 T3852 advcl peaked,inhibit
R3020 T3875 T3852 punct .,inhibit